Cas:1058656-05-5 2-Ethylimidazo[1,2-a]pyridin-8-ol manufacturer & supplier

Chemical Name:2-Ethylimidazo[1,2-a]pyridin-8-ol

CAS.NO:1058656-05-5

Synonyms:2-Ethylimidazo[1,2-a]pyridin-8-ol

Molecular Formula:C₉H₁₀N₂O

Molecular Weight:162.18800

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:37.53000

Exact Mass:162.07900

LogP:1.60230

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-Ethylimidazo[1,2-a]pyridin-8-ol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Ethylimidazo[1,2-a]pyridin-8-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Ethylimidazo[1,2-a]pyridin-8-ol Use and application,2-Ethylimidazo[1,2-a]pyridin-8-ol technical grade,usp/ep/jp grade.

Related News: The Philippines reported its first Wuhan coronavirus fatality on Sunday. 2-Ethylimidazo[1,2-a]pyridin-8-ol manufacturer Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection. 2-Ethylimidazo[1,2-a]pyridin-8-ol supplier The outlook for a cure is clouded with theoretical uncertainties and high-profile failures. Pharmaceutical giants including Johnson & Johnson, Merck and Pfizer have ditched their projects on unsatisfactory data. 2-Ethylimidazo[1,2-a]pyridin-8-ol vendor Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself. 2-Ethylimidazo[1,2-a]pyridin-8-ol factory Today, Novavax is one step closer to addressing the critical and persistent global public health need for additional COVID-19 vaccines,” Novavax president and CEO Stanley Erck said in a statement. “These clinical results reinforce that [the vaccine] is extremely effective and offers complete protection against both moderate and severe COVID-19 infection.